Literature DB >> 7758255

Implementation of intensified insulin therapy: a European perspective.

M Berger1, I Mühlhauser.   

Abstract

The Diabetes Education Study Group (DESG) of the European Association for the Study of Diabetes (EASD) was founded in 1979 with its major goal to make effective patient training an integral part of any diabetes therapy. Within the DESG, a number of models for structured diabetes treatment and teaching programmes were developed. Concerning the care of persons with Type 1 diabetes, substantial emphasis was placed upon the 5-day in-patient treatment and teaching programme for groups of 6 to 10 patients as originally introduced at the University of Geneva and further developed for general use at the University of Düsseldorf. During the early 1980s, this programme was based upon intensified insulin therapy including a stepwise liberalization of previously rigid rules for nutrition and life schedules. In several European centres the programme was continuously evaluated and shown to be effective as documented by significant reductions of glycated haemoglobin values, episodes of ketoacidosis, hospitalizations, and sick-day leaves. In contrast to the Diabetes Control and Complications Trial (DCCT) the improvement of glycated haemoglobin values was not associated with an increased risk of severe hypoglycaemia. Possible reasons for this favourable outcome are discussed. During recent years the 5-day treatment and teaching programme for Type 1 diabetes has been translated into the general health care system of Germany without any loss of its efficacy. In addition, in various other European countries, model centres of diabetes care have implemented the 5-day programme, and for a number of these centres, its efficacy to improve the overall quality of diabetes care has been published or presented at meetings.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7758255     DOI: 10.1111/j.1464-5491.1995.tb00459.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  8 in total

1.  Hypertension guidelines and their effects on the health system.

Authors:  Wilhelm Frank; Brigitte Konta
Journal:  GMS Health Technol Assess       Date:  2005-12-21

Review 2.  To bridge science and patient care in diabetes.

Authors:  M Berger
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

3.  Hypoglycemia impairs quality of blood glucose simulation in a clinical decision support system.

Authors:  Mette Dencker Johansen; Ole K Hejlesen; David A Cavan
Journal:  J Diabetes Sci Technol       Date:  2011-07-01

4.  The JEVIN trial: a population-based survey on the quality of diabetes care in Germany: 1994/1995 compared to 1989/1990.

Authors:  R Schiel; U A Müller; H Sprott; A Schmelzer; B Mertes; W Hunger-Dathe; I S Ross
Journal:  Diabetologia       Date:  1997-11       Impact factor: 10.122

Review 5.  Dose adjustment for normal eating: a role for the expert patient?

Authors:  Harold David McIntyre
Journal:  Diabetes Metab J       Date:  2014-04       Impact factor: 5.376

6.  Flexible insulin therapy improves metabolic control and decreases the risk of hypoglycemia in type 1 diabetic patients.

Authors:  Siham Rouf; Amine Ezzerrouqi; Salma Benyakhlef; Naima Abda; Hanane Latrech
Journal:  Pan Afr Med J       Date:  2021-10-14

Review 7.  Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.

Authors:  Birgit Fullerton; Klaus Jeitler; Mirjam Seitz; Karl Horvath; Andrea Berghold; Andrea Siebenhofer
Journal:  Cochrane Database Syst Rev       Date:  2014-02-14

Review 8.  Carbohydrate restriction for diabetes: rediscovering centuries-old wisdom.

Authors:  Belinda S Lennerz; Andrew P Koutnik; Svetlana Azova; Joseph I Wolfsdorf; David S Ludwig
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.